A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma

✍ Scribed by S. Jagannath; B. Barlogie; J. Berenson; D. Siegel; D. Irwin; P. G. Richardson; R. Niesvizky; R. Alexanian; S. A. Limentani; M. Alsina; J. Adams; M. Kauffman; D.-L. Esseltine; D. P. Schenkein; K. C. Anderson

• Book ID: 108672870
• Publisher: John Wiley and Sons
• Year: 2004
• Tongue: English
• Weight: 190 KB
• Volume: 127
• Category: Article
• ISSN: 0007-1048
• DOI: 10.1111/j.1365-2141.2004.05188.x